Fortrea to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 06 2023 - 11:00AM
Fortrea (Nasdaq: FTRE), a leading global contract research
organization (CRO), today announced that Chairman and Chief
Executive Officer, Tom Pike and Chief Financial Officer, Jill
McConnell will participate in a fireside chat at the Morgan Stanley
21st Annual Global Healthcare Conference on Wednesday, September 13
at 9:30 am ET.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical
development and patient access solutions to the life sciences
industry. We partner with emerging and large biopharmaceutical,
medical device and diagnostic companies to drive healthcare
innovation that accelerates life changing therapies to patients in
need. Fortrea provides phase I-IV clinical trial management,
clinical pharmacology, differentiated technology enabled trial
solutions and post-approval services.
Fortrea’s solutions leverage three decades of experience
spanning more than 20 therapeutic areas, a passion for scientific
rigor, exceptional insights and a strong investigator site network.
Our talented and diverse team of more than 19,000 people working in
more than 90 countries is scaled to deliver focused and agile
solutions to customers globally.
Learn more about how Fortrea is becoming a transformative force
from pipeline to patient at Fortrea.com and follow us on LinkedIn
and Twitter @Fortrea.
Fortrea Contacts
Hima Inguva (Investors) – 877-495-0816,
hima.inguva@fortrea.comSue Zaranek (Media) – 919-943-5422,
media@fortrea.comKate Dillon (Media) – 646-818-9115,
kdillon@prosek.com
Fortrea (NASDAQ:FTRE)
Historical Stock Chart
From Dec 2024 to Jan 2025
Fortrea (NASDAQ:FTRE)
Historical Stock Chart
From Jan 2024 to Jan 2025